Treatment for Reading and Writing Deficits Following Acquired Brain Injury
NCT ID: NCT03662243
Last Updated: 2021-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2018-08-30
2020-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ReadMap: Reading in Stroke Alexia and Typical Aging
NCT06700005
Pairing Word Retrieval and Physical Endurance Tasks to Treat Anomia in People With Aphasia
NCT03326687
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
NCT03662295
Links Between Motor Abilities and Language Ability Deficits in Patients With Post-stroke Aphasia
NCT05776368
Brain Mechanisms Underlying Reading Improvement in Central Alexia
NCT02062619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acquired brain injury participants
People with acquired alexia and/or agraphia secondary to brain injury who participate in the reading/writing intervention.
Multicomponent reading and writing treatment
Intervention procedures incorporated into the program include drilling on sight words to improve immediate recognition of common words; engaging in Multiple Oral Reading procedures to increase reading fluency; practicing oral spelling of sight words to improve spelling accuracy; generating written sentences to improve accurate spelling and use of written conventions (e.g., punctuation, capitalization); and summarizing and subsequently writing sentences about read material to establish strategies to enhance reading comprehension and promote written expression.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multicomponent reading and writing treatment
Intervention procedures incorporated into the program include drilling on sight words to improve immediate recognition of common words; engaging in Multiple Oral Reading procedures to increase reading fluency; practicing oral spelling of sight words to improve spelling accuracy; generating written sentences to improve accurate spelling and use of written conventions (e.g., punctuation, capitalization); and summarizing and subsequently writing sentences about read material to establish strategies to enhance reading comprehension and promote written expression.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Exhibits alexia and/or agraphia
* Past or current client of Quality Living, Inc., Omaha, Nebraska
* Fluent speaker of English
Exclusion Criteria
* Auditory comprehension problems precluding understanding of consent/assent information
14 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quality Living, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Hux
Director of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Hux, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Quality Living, Inc., Omaha, Nebraska
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Quality Living, Inc.
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Reading/writing treatment
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.